Circio announces novel circVec 3.0 generation and circular mRNA half-life up to 75 times longer than linear mRNA in vivo
· Novel circVec 3.0 design feature achieves 27- and 4-fold improvement vs. circVec 1.1 and 2.1 generation, respectively · circVec circular mRNA shows up to 75 times longer half-life than conventional linear mRNA in vivo · Muscle-specific circVec 2.0-AAV vectors validated by systemic delivery in vivo · The results will be discussed in a live webcast